CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- 8-K Event Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- S-4 Deal Registration Statement - Business Combination
- 4 Open-market buy CCO & EVP, Bus. Development bought 500 shares at $5.13 ($2,565)
- 4 Open-market buy CFO, Secretary & Treasurer bought 1,000 shares at $4.96 ($4,959)
- 4 Open-market buy Director bought 10,000 shares at $5.13 ($51,333)
- 4 Open-market buy Director bought 10,000 shares at $4.88 ($48,764)
Page 11 of 44 · 870 filings